384 related articles for article (PubMed ID: 30153844)
1. Automatic evaluation of tumor budding in immunohistochemically stained colorectal carcinomas and correlation to clinical outcome.
Weis CA; Kather JN; Melchers S; Al-Ahmdi H; Pollheimer MJ; Langner C; Gaiser T
Diagn Pathol; 2018 Aug; 13(1):64. PubMed ID: 30153844
[TBL] [Abstract][Full Text] [Related]
2. Digital image analysis of pan-cytokeratin stained tumor slides for evaluation of tumor budding in pT1/pT2 colorectal cancer: Results of a feasibility study.
Jepsen RK; Klarskov LL; Lippert MF; Novotny GW; Hansen TP; Christensen IJ; Høgdall E; Riis LB
Pathol Res Pract; 2018 Sep; 214(9):1273-1281. PubMed ID: 30017334
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical evaluation of tumor budding for stratifying T1 colorectal cancer: optimal cut-off value and a novel computer-assisted semiautomatic method.
Takamatsu M; Kawachi H; Yamamoto N; Kobayashi M; Toyama Y; Maekawa T; Chino A; Saito S; Ueno M; Takazawa Y; Ishikawa Y
Mod Pathol; 2019 May; 32(5):675-683. PubMed ID: 30552417
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive assessment of tumour budding by cytokeratin staining in colorectal cancer.
Rieger G; Koelzer VH; Dawson HE; Berger MD; Hädrich M; Inderbitzin D; Lugli A; Zlobec I
Histopathology; 2017 Jun; 70(7):1044-1051. PubMed ID: 28061021
[TBL] [Abstract][Full Text] [Related]
5. Development of a semi-automated method for tumour budding assessment in colorectal cancer and comparison with manual methods.
Fisher NC; Loughrey MB; Coleman HG; Gelbard MD; Bankhead P; Dunne PD
Histopathology; 2022 Feb; 80(3):485-500. PubMed ID: 34580909
[TBL] [Abstract][Full Text] [Related]
6. Assessment of individual tumor buds using keratin immunohistochemistry: moderate interobserver agreement suggests a role for machine learning.
Bokhorst JM; Blank A; Lugli A; Zlobec I; Dawson H; Vieth M; Rijstenberg LL; Brockmoeller S; Urbanowicz M; Flejou JF; Kirsch R; Ciompi F; van der Laak JAWM; Nagtegaal ID
Mod Pathol; 2020 May; 33(5):825-833. PubMed ID: 31844269
[TBL] [Abstract][Full Text] [Related]
7. Tumor budding at the invasive front of colorectal cancer may not be associated with the epithelial-mesenchymal transition.
Yamada N; Sugai T; Eizuka M; Tsuchida K; Sugimoto R; Mue Y; Suzuki M; Osakabe M; Uesugi N; Ishida K; Otsuka K; Matsumoto T
Hum Pathol; 2017 Feb; 60():151-159. PubMed ID: 27836787
[TBL] [Abstract][Full Text] [Related]
8. Combined epithelial marker analysis of tumour budding in stage II colorectal cancer.
Slik K; Blom S; Turkki R; Välimäki K; Kurki S; Mustonen H; Haglund C; Carpén O; Kallioniemi O; Korkeila E; Sundström J; Pellinen T
J Pathol Clin Res; 2019 Jan; 5(1):63-78. PubMed ID: 30358171
[TBL] [Abstract][Full Text] [Related]
9. Tumor budding in colorectal cancer revisited: results of a multicenter interobserver study.
Koelzer VH; Zlobec I; Berger MD; Cathomas G; Dawson H; Dirschmid K; Hädrich M; Inderbitzin D; Offner F; Puppa G; Seelentag W; Schnüriger B; Tornillo L; Lugli A
Virchows Arch; 2015 May; 466(5):485-93. PubMed ID: 25701480
[TBL] [Abstract][Full Text] [Related]
10. Tumor Budding Detection System in Whole Slide Pathology Images.
Fauzi MFA; Chen W; Knight D; Hampel H; Frankel WL; Gurcan MN
J Med Syst; 2019 Dec; 44(2):38. PubMed ID: 31853654
[TBL] [Abstract][Full Text] [Related]
11. Tumor budding in colorectal carcinoma: An institutional interobserver reliability and prognostic study of colorectal adenocarcinoma cases.
Hacking S; Angert M; Jin C; Kline M; Gupta N; Cho M; Thomas R; Lee L; Chavarria H; Nasim M
Ann Diagn Pathol; 2019 Dec; 43():151420. PubMed ID: 31731034
[TBL] [Abstract][Full Text] [Related]
12. Linear quantification of lymphoid infiltration of the tumor margin: a reproducible method, developed with colorectal cancer tissues, for assessing a highly variable prognostic factor.
Allard MA; Bachet JB; Beauchet A; Julie C; Malafosse R; Penna C; Nordlinger B; Emile JF
Diagn Pathol; 2012 Nov; 7():156. PubMed ID: 23148481
[TBL] [Abstract][Full Text] [Related]
13. Semi-Supervised Learning to Automate Tumor Bud Detection in Cytokeratin-Stained Whole-Slide Images of Colorectal Cancer.
Bokhorst JM; Nagtegaal ID; Zlobec I; Dawson H; Sheahan K; Simmer F; Kirsch R; Vieth M; Lugli A; van der Laak J; Ciompi F
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046742
[TBL] [Abstract][Full Text] [Related]
14. Tumor budding in colorectal cancer--ready for diagnostic practice?
Koelzer VH; Zlobec I; Lugli A
Hum Pathol; 2016 Jan; 47(1):4-19. PubMed ID: 26476568
[TBL] [Abstract][Full Text] [Related]
15. Impact of peritumoral and intratumoral budding in esophageal adenocarcinomas.
Thies S; Guldener L; Slotta-Huspenina J; Zlobec I; Koelzer VH; Lugli A; Kröll D; Seiler CA; Feith M; Langer R
Hum Pathol; 2016 Jun; 52():1-8. PubMed ID: 26980046
[TBL] [Abstract][Full Text] [Related]
16. Tumor budding and human chorionic gonadotropin-β expression correlate with unfavorable patient outcome in colorectal carcinoma.
Konishi Y; Kawamata F; Nishihara H; Homma S; Kato Y; Tsuda M; Kohsaka S; Einama T; Liu C; Yoshida T; Nagatsu A; Tanino M; Tanaka S; Kawamura H; Kamiyama T; Taketomi A
Med Oncol; 2018 Jun; 35(7):104. PubMed ID: 29892782
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of tumor budding in endometrial carcinoma within distinct molecular subgroups.
Rau TT; Bettschen E; Büchi C; Christe L; Rohner A; Müller MD; Carlson JW; Imboden S; Zlobec I
Mod Pathol; 2021 Jan; 34(1):222-232. PubMed ID: 32728223
[TBL] [Abstract][Full Text] [Related]
18. Fully Automated Tumor Bud Assessment in Hematoxylin and Eosin-Stained Whole Slide Images of Colorectal Cancer.
Bokhorst JM; Ciompi F; Öztürk SK; Oguz Erdogan AS; Vieth M; Dawson H; Kirsch R; Simmer F; Sheahan K; Lugli A; Zlobec I; van der Laak J; Nagtegaal ID
Mod Pathol; 2023 Sep; 36(9):100233. PubMed ID: 37257824
[TBL] [Abstract][Full Text] [Related]
19. High-grade intratumoral tumor budding is a predictor for lymphovascular invasion and adverse outcome in stage II colorectal cancer.
Marx AH; Mickler C; Sauter G; Simon R; Terracciano LM; Izbicki JR; Clauditz TS
Int J Colorectal Dis; 2020 Feb; 35(2):259-268. PubMed ID: 31838579
[TBL] [Abstract][Full Text] [Related]
20. Expression of the hyaluronan-mediated motility receptor RHAMM in tumor budding cells identifies aggressive colorectal cancers.
Koelzer VH; Huber B; Mele V; Iezzi G; Trippel M; Karamitopoulou E; Zlobec I; Lugli A
Hum Pathol; 2015 Nov; 46(11):1573-81. PubMed ID: 26351067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
